Carregant...
Long-term Follow-up of Autosomal Dominant Stargardt Macular Dystrophy (STGD3) Subjects Enrolled in a Fish Oil Supplement Interventional Trial
BACKGROUND: Earlier studies have raised the notion that docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) supplementation could be a useful intervention in autosomal dominant Stargardt macular dystrophy (STGD3). We sought to assess whether fish oil supplementation has a beneficial effect on...
Guardat en:
| Publicat a: | Ophthalmic Genet |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6082669/ https://ncbi.nlm.nih.gov/pubmed/29377748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13816810.2018.1430240 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|